Teirraha Lowe
Pediatrics · Mount Airy, NCNPI 1124652433
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 301 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 34 manufacturers reported payments, led by Novo Nordisk at 25.5% of the total. Reporting peaked in 2021 at $1,684 and has fallen 70.5% since, to $497 in 2025. Among pediatrics clinicians in NC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 301 payments — averaging $16.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$635
- Amgen$428
- Pfizer$306
- Sanofi-aventis U.S. LLC$167
- Exact Sciences$166
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,833100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 78 | $1,234 |
| AbbVie | 42 | $635 |
| Amgen | 27 | $428 |
| Pfizer | 19 | $306 |
| Sanofi-aventis U.S. LLC | 10 | $167 |
| Exact Sciences | 8 | $166 |
| Boehringer Ingelheim | 11 | $153 |
| Phathom Pharmaceuticals, Inc. | 7 | $152 |
| Lilly USA, LLC | 11 | $150 |
| Amarin Pharma, Inc. | 8 | $128 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $126 |
| Merck | 8 | $125 |
| AstraZeneca | 8 | $120 |
| Paratek Pharmaceuticals, Inc. | 8 | $109 |
| Mylan Specialty L.p. | 6 | $107 |
| GSK | 6 | $86 |
| Kowa Pharmaceuticals America, Inc. | 6 | $86 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $82 |
| Eisai Inc. | 5 | $81 |
| Novartis | 3 | $56 |
| Vertex | 2 | $49 |
| Johnson & Johnson | 3 | $39 |
| Ironshore Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Viatris Specialty LLC | 1 | $32 |
| Bayer | 1 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Biohaven Pharmaceuticals, Inc. | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
| Sobi, Inc | 1 | $13 |
| IBSA Pharma Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,833 in reported general payments places this provider in the 95th percentile of 1,818 pediatrics providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Guanfacine Hcl ErGuanfacine Hcl | 12 | $276 |
| Esomeprazole Magnesium | 12 | $107 |
| Quetiapine Fumarate | 11 | $20 |
Paid to pharmacies, not to this prescriber.
Other pediatrics in Mount Airy
- Dwight KoeberlDurham$8.4M
- Priya KishnaniDurham$5.8M
- James AndersonHigh Point$669K
- Joseph MuenzerChapel Hill$237K
- Ifeyinwa OsunkwoCharlotte$218K
- Edward SmithDurham$164K
- Katherine SmithRaleigh$133K
- James StillRaleigh$105K
- Richard BrugmanGastonia$73K
- Daniel LandiDurham$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.